Latest Breaking News On - Global health discovery - Page 1 : comparemela.com

Janssen (JNJ) Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

Janssen (JNJ) Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarnix van loockRuxandra draghia akliWalter reed army institute of researchJanssen research developmentJanssen pharmaceutical companies of johnsonGlobal health discovery atMarseille universityDepartment of infectious diseases at heidelberg universityUniversity of texas medical branch healthBiomedical primate research centreGlobal public healthSealy institute for vaccine sciencesDepartment of virologyCompanies of johnsonKu leuven centre for drug design

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarnix van loockRuxandra draghia akliTesia williamsTrish garrityWalter reed army institute of researchJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonGlobal health discovery atMarseille universityDepartment of infectious diseases at heidelberg universityUniversity of texas medical branch healthNone of the janssen pharmaceutical companiesBiomedical primate research centreGlobal public health

Johnson & Johnson: Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans Findings support further clinical development for prevention and treatment of dengue, which impacts millions

United statesBaden wübergDennis riedlRuxandra draghia akliMarnix van loockTesia williamsTrish garrityWalter reed army institute of researchJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonGlobal health discovery atMarseille universityDepartment of infectious diseases at heidelberg universityUniversity of texas medical branch healthNone of the janssen pharmaceutical companies

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nat

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humansFindings support further clinical development for prevention and treatment of dengue, which impacts millions of people today and is poised to threaten many more due to climate changeResearch builds on Johnson & Johnson’s endu.

United statesMarnix van loockRuxandra draghia akliTesia williamsTrish garrityWalter reed army institute of researchJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonGlobal health discovery atMarseille universityDepartment of infectious diseases at heidelberg universityUniversity of texas medical branch healthNone of the janssen pharmaceutical companiesBiomedical primate research centreGlobal public health

OPINION | Africa is ready to be recognised as a source of health innovation

Overdependence on health innovations developed in the global north is not sustainable and cannot continue if Africa is to be on a path to self-sufficiency write Susan Winks and Kelly Chibale.

United statesUnited kingdomSouth africaSouth africanKelly chibaleTechnology innovation agencyDepartment of scienceCfd centreAfrican medical research councilStrategic health innovation partnershipsD centre at university of cape townSusan winksHolistic drug discoveryCape townMalaria ventureSouth african medical research council